UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010-06, Vol.13 (2), p.90-94

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors and Subjective Symptoms of Drug-induced Leucopenia

YAKUGAKU ZASSHI, 2011/01/01, Vol.131(1), pp.139-152

2011

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study

PloS one, 2016-12, Vol.11 (12), p.e0168707-e0168707

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of response of patients with solid tumors to granulocyte colony-stimulating factor

International journal of clinical pharmacy, 2013-02, Vol.35 (1), p.45-50

2013

Link zum Volltext

Verfügbarkeit prüfen

No association of an SDHC gene polymorphism with gastric cancer

Asian Pacific journal of cancer prevention : APJCP, 2006-10, Vol.7 (4), p.525

2006

Link zum Volltext

Verfügbarkeit prüfen

Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2005-02, Vol.8 (1), p.12-17

2005

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer: combined analyses from two Phase II studies

Future oncology (London, England), 2016-09, Vol.12 (18), p.2117-2126

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation

Hepato-gastroenterology, 2012-11, Vol.59 (120), p.2361

2012

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of Thyroid and Neck Lymph Node Screening with Carotid Artery Ultrasonography

Nippon Jibiinkoka Gakkai Kaiho, 2014/07/20, Vol.117(7), pp.914-921

2014

Link zum Volltext

Verfügbarkeit prüfen

No association between the CDX2 G543C polymorphism and risk of gastric atrophy and cancer

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (11), p.5691-5694

2012

Link zum Volltext

Verfügbarkeit prüfen

Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping

Nagoya journal of medical science, 2011-02, Vol.73 (1-2), p.25-31

2011

Link zum Volltext

Verfügbarkeit prüfen

The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis

Asian Pacific journal of cancer prevention : APJCP, 2005-10, Vol.6 (4), p.464-467

2005

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of intracellular 1-β-D-arabinofuranosylcytosine 5'-triphosphate in 1-β-D-arabinofuranosylcytosine therapy at low and conventional doses

Japanese journal of cancer research (Gann), 2001-05, Vol.92 (5), p.546-553

2001

Link zum Volltext

Verfügbarkeit prüfen

No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T

Nagoya journal of medical science, 2007, Vol.69 (1-2), p.17-22

2007

Link zum Volltext

Verfügbarkeit prüfen

Bayesian Forecasting of Plasma Vancomycin Concentration Using Time-Dependent Pharmacokinetics

YAKUGAKU ZASSHI, 1996/11/25, Vol.116(11), pp.876-883

1996

Link zum Volltext

Verfügbarkeit prüfen

Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia

Japanese journal of cancer research (Gann), 2001-09, Vol.92 (9), p.975

2001

Link zum Volltext

Verfügbarkeit prüfen

Grb2-associated binder 1 polymorphism was associated with the risk of Helicobactor pylori infection and gastric atrophy

International journal of medical sciences, 2006-11, Vol.4 (1), p.1-6

2006

Link zum Volltext

Verfügbarkeit prüfen

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3335-3341

2013

Link zum Volltext

Verfügbarkeit prüfen

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.195-199

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 141

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Complete

SpracheDeutsch

ThemaAged, 80 And Over

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(141)

Sprache

Englisch
(138)
Japanisch
(47)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No Association Between EGF Gene Polymorphism and Gastric Cancer

Inducible nitric oxide synthase polymorphism is associated with the increased risk of differentiated gastric cancer in a Japanese population

Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial

A C to T polymorphism of urokinase plasminogen activator (P141L) is associated with Helicobacter pylori infection

Development and Validation of Estimate Equations for Adverse Drug Reactions Using Risk Factors and Subjective Symptoms

PRKCH gene polymorphism is associated with the risk of severe gastric atrophy

Risk Factors and Subjective Symptoms of Drug-induced Leucopenia

Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study

Predictors of response of patients with solid tumors to granulocyte colony-stimulating factor

No association of an SDHC gene polymorphism with gastric cancer

Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees

Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer: combined analyses from two Phase II studies

Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation

Usefulness of Thyroid and Neck Lymph Node Screening with Carotid Artery Ultrasonography

No association between the CDX2 G543C polymorphism and risk of gastric atrophy and cancer

Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping

The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis

Monitoring of intracellular 1-β-D-arabinofuranosylcytosine 5'-triphosphate in 1-β-D-arabinofuranosylcytosine therapy at low and conventional doses

No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T

Bayesian Forecasting of Plasma Vancomycin Concentration Using Time-Dependent Pharmacokinetics

Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia

Grb2-associated binder 1 polymorphism was associated with the risk of Helicobactor pylori infection and gastric atrophy

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Aktive Filter

Suchergebnisse filtern